NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1275072804|gb|ATS48688|]
View 

beta-xylosidase [Xanthomonas citri pv. phaseoli var. fuscans]

Protein Classification

Ig and FN3 domain-containing protein; fibronectin type III domain-containing protein; purple acid phosphatase N-terminal domain-containing protein; receptor tyrosine-protein kinase( domain architecture ID 10007666)

Ig and FN3 domain-containing protein similar to Homo sapiens contactins, which are comprised of six immunoglobulin (Ig)-like domains followed by four fibronectin type III (Fn3) domains anchored to the membrane by glycosylphosphatidylinositol, and to Robo (roundabout) receptors which typically contain five Ig-like domains and three FN3 domains; fibronectin type III (FN3) domain-containing protein may be involved in specific interactions with other molecules through its FN3 domain; fibronectin type III (FN3) domain-containing protein may be involved in specific interactions with other molecules through its FN3 domain; fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III (FN3) domain-containing protein such as mammalian interleukin-7 receptor subunit alpha; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein such as Drosophila melanogaster Ihog (interference hedgehog) and human neural cell adhesion molecule (NCAM); fibronectin type III (FN3) domain-containing protein may be involved in specific interactions with other molecules through its FN3 domain; fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III (FN3) domain-containing protein such as mammalian interleukin-7 receptor subunit alpha; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein such as Drosophila melanogaster Ihog (interference hedgehog) and human neural cell adhesion molecule (NCAM); fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III (FN3) domain-containing protein may be involved in specific interactions with other molecules through its FN3 domain; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III (FN3) domain-containing protein similar to human Target of Nesh-SH3 (Tarsh) and Drosophila melanogaster cytokine receptor (protein domeless); fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; fibronectin type III domain-containing protein similar to mammalian interleukin-9 and interleukin-21 receptors, and vertebrate phytanoyl-CoA hydroxylase-interacting protein; purple acid phosphatase N-terminal domain-containing protein; receptor tyrosine-protein kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates, similar to Sus scrofa insulin-like growth factor 1 (IGF1) receptor that binds IGF1 with high affinity and IGF2 and insulin with a lower affinity

Gene Ontology:  GO:0005515
PubMed:  8981327

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
XynB COG3664
Beta-xylosidase [Carbohydrate transport and metabolism];
16-517 0e+00

Beta-xylosidase [Carbohydrate transport and metabolism];


:

Pssm-ID: 442881  Cd Length: 490  Bit Score: 591.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  16 TSAMAQHAAPRTIQLDLATAGAPVDRFYDLSVGSDFPGTlirsdaqahlvpavhelgFRYLRFHDVFHDVLGTVK-TVDG 94
Cdd:COG3664    25 KVAGPMKPLWAWFGYDEPNYTYMKDGKKLLSEGAGLSPV------------------FRYIRFHGLFHDDMGVYReDADG 86
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  95 KLVYDWTKLDQLYDALLAKRIRPFVELGFTPSAMKTSEQTLFYWKGNTSHP-DPAKWTQLIDAYVRHIRARYGAEEVRQW 173
Cdd:COG3664    87 NPVYNFTYVDKIFDFLLELGMKPFVELGFMPEALASGPQTVFWWKGNVTPPkDYAKWADLVRAFVRHLIDRYGIDEVRSW 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 174 YFEVWNEPNLKDFWEnADQQAYFDLYANTARTIKAIDPQLRVGGPSTAG--AAWVPELLAFAAKNTLPIDFVTTHTYGVD 251
Cdd:COG3664   167 YFEVWNEPNLSGFWK-GTQEEYFKLYDYTARAVKSVDPRLRVGGPATAGgaAAWLPDFLEHCAKNGVPVDFVSTHAYGTD 245
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 252 GGFldengkqDTKLSASPDAIVGDVRRVRAQIQASPFPDLPLYFTEWSSSYTPRDFVHDSYISAPYILTKLKQVRGMVQG 331
Cdd:COG3664   246 PGF-------DGQLSMNPDAVLRDVEKVRKLIAASAFPNLPLHITEWNTSYTPRDPYHDTAFYAAYIAKSLKRAGDLADS 318
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 332 MSYWTYTDLFEEPGPPPTPFHGGFGLMNREGIRKPAWFAYKYLNALKGRDVPLSDTHALAAVDG-KRVAALAWDWQQPvq 410
Cdd:COG3664   319 MSYWTFSDIFEEAGPPTQPFHGGFGLLNTNGIKKPVYHAFRMLNRLGGERLAVGDDDAVATRDDdGRVAVLVWNYHDD-- 396
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 411 avsntpfytkqVPATDSAPLRVRMTHVPAGTYQLQVRKTGYRRNDPLSLYIDMGMPNDLAPRQLTQLQQATRDAPEqdRR 490
Cdd:COG3664   397 -----------DPAGPARTVELTLTGLPAGKYRLTVYRVDEEHGNAYAAWLEMGSPQQPTREQIAELKAAAELQTS--PE 463
                         490       500
                  ....*....|....*....|....*..
gi 1275072804 491 VRVGADGVVEINVPMRSNDVVLLTLEP 517
Cdd:COG3664   464 VVVVADGKLTLDLTLPRNSVVLIELTP 490
 
Name Accession Description Interval E-value
XynB COG3664
Beta-xylosidase [Carbohydrate transport and metabolism];
16-517 0e+00

Beta-xylosidase [Carbohydrate transport and metabolism];


Pssm-ID: 442881  Cd Length: 490  Bit Score: 591.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  16 TSAMAQHAAPRTIQLDLATAGAPVDRFYDLSVGSDFPGTlirsdaqahlvpavhelgFRYLRFHDVFHDVLGTVK-TVDG 94
Cdd:COG3664    25 KVAGPMKPLWAWFGYDEPNYTYMKDGKKLLSEGAGLSPV------------------FRYIRFHGLFHDDMGVYReDADG 86
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  95 KLVYDWTKLDQLYDALLAKRIRPFVELGFTPSAMKTSEQTLFYWKGNTSHP-DPAKWTQLIDAYVRHIRARYGAEEVRQW 173
Cdd:COG3664    87 NPVYNFTYVDKIFDFLLELGMKPFVELGFMPEALASGPQTVFWWKGNVTPPkDYAKWADLVRAFVRHLIDRYGIDEVRSW 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 174 YFEVWNEPNLKDFWEnADQQAYFDLYANTARTIKAIDPQLRVGGPSTAG--AAWVPELLAFAAKNTLPIDFVTTHTYGVD 251
Cdd:COG3664   167 YFEVWNEPNLSGFWK-GTQEEYFKLYDYTARAVKSVDPRLRVGGPATAGgaAAWLPDFLEHCAKNGVPVDFVSTHAYGTD 245
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 252 GGFldengkqDTKLSASPDAIVGDVRRVRAQIQASPFPDLPLYFTEWSSSYTPRDFVHDSYISAPYILTKLKQVRGMVQG 331
Cdd:COG3664   246 PGF-------DGQLSMNPDAVLRDVEKVRKLIAASAFPNLPLHITEWNTSYTPRDPYHDTAFYAAYIAKSLKRAGDLADS 318
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 332 MSYWTYTDLFEEPGPPPTPFHGGFGLMNREGIRKPAWFAYKYLNALKGRDVPLSDTHALAAVDG-KRVAALAWDWQQPvq 410
Cdd:COG3664   319 MSYWTFSDIFEEAGPPTQPFHGGFGLLNTNGIKKPVYHAFRMLNRLGGERLAVGDDDAVATRDDdGRVAVLVWNYHDD-- 396
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 411 avsntpfytkqVPATDSAPLRVRMTHVPAGTYQLQVRKTGYRRNDPLSLYIDMGMPNDLAPRQLTQLQQATRDAPEqdRR 490
Cdd:COG3664   397 -----------DPAGPARTVELTLTGLPAGKYRLTVYRVDEEHGNAYAAWLEMGSPQQPTREQIAELKAAAELQTS--PE 463
                         490       500
                  ....*....|....*....|....*..
gi 1275072804 491 VRVGADGVVEINVPMRSNDVVLLTLEP 517
Cdd:COG3664   464 VVVVADGKLTLDLTLPRNSVVLIELTP 490
Glyco_hydro_39 pfam01229
Glycosyl hydrolases family 39;
28-506 9.63e-100

Glycosyl hydrolases family 39;


Pssm-ID: 426141  Cd Length: 472  Bit Score: 308.77  E-value: 9.63e-100
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  28 IQLDLATAGAPVDRFYDLSVGSDFPGTLIRSDAQAHLVPAVHELGFRYLRFHDVFHDVLGTV-KTVDGKLVYDWTKLDQL 106
Cdd:pfam01229   3 IKVDAARDLRKLTPFWRSCVGFCPPLPALQADWDQQLNLAYPHIGFEYVRGHGWLLDDITAYrESVDQGLFYNFTHIDRI 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 107 YDALLAKRIRPFVELGFTPSAMKTSEQTLFYWKGNTSHP-DPAKWTQLIDAYVRHIRARYGAEEVRQWYFEVWNEPNLKD 185
Cdd:pfam01229  83 LDLLLENGLLPFFELGFMPKRLASGTPTVFFWEGNFTPPkQYEEWKNLVSLLARHYIGRYGLDEVSKWNFETWNEPNLKD 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 186 F-WENADQQAYFDLYANTARTIKAIDPQLRVGGPSTAGAAWVPELLAFAAKNTLPIDFVTTHTYGVDGGFLDENGKQDTK 264
Cdd:pfam01229 163 FdWVDMTEQEYFNLYKACAEAIKEVSPNLKVGGPADSFDPWIRSLLEFCYNGNVPLDFISLHAYSKKGAGSSILILEEEM 242
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 265 LSASPDAIVGDVRRVRAQiqaspFPDLPLYFTEWSSSYTPRDFVHDSYISAPYILTKLKQVRGMVQGMSYWTYTDLFEEP 344
Cdd:pfam01229 243 ASEYMLNEVKQVRELIPE-----FPDLPVYNTEANPSWSPPQPWHDDPTYAAYVVKVIAQHQDLPDANSYWTFRDVFEEN 317
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 345 GPPPTPFHGGFGLMNREGIRKPAWFAYKYLNALKGRDV--PLSDTH----ALAAVDGKRVAALAWDWQQPVQAVSNTPFY 418
Cdd:pfam01229 318 DNAFLSFHGGFGLNNTHPIPKPVLTAFKLLALLDGEQLwaEVSDSNhtvgVIASRHDPSGALIAWNEIVLIYSSDDTTAH 397
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 419 tkqvpATDSAPLRVRMTHVPAGTYQLQVRKTGYRRNDPLSLYIDMGmpndlAPRQLTQlqqatrdapEQDRRVRVGADGV 498
Cdd:pfam01229 398 -----PDKEYPVTLRLNGPVGFKLVYIKLMIDEDHGNPWGTWQHMG-----RPVFPSK---------EQIRRLRDAEKPK 458

                  ....*...
gi 1275072804 499 VEINVPMR 506
Cdd:pfam01229 459 AEAPRPFP 466
agarase_cat cd21510
alpha-beta barrel catalytic domain of agarase, such as GH86-like endo-acting agarases ...
174-248 2.26e-05

alpha-beta barrel catalytic domain of agarase, such as GH86-like endo-acting agarases identified in non-marine organisms; Typically, agarases (E.C. 3.2.1.81) are found in ocean-dwelling bacteria since agarose is a principle component of red algae cell wall polysaccharides. Agarose is a linear polymer of alternating D-galactose and 3,6-anhydro-L-galactopyranose. Endo-acting agarases, such as glycoside hydrolase 16 (GH16) and GH86 hydrolyze internal beta-1,4 linkages. GH86-like endo-acting agarase of this protein family has been identified in the human intestinal bacterium Bacteroides uniformis. This acquired metabolic pathway, as demonstrated by the prevalence of agar-specific genetic cluster called polysaccharide utilization loci (PULs), varies considerably between human populations, being much more prevalent in a Japanese sample than in North America, European, or Chinese samples. Agarase activity was also identified in the non-marine bacterium Cellvibrio sp.


Pssm-ID: 411072  Cd Length: 321  Bit Score: 46.41  E-value: 2.26e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 174 YFEVWNEPNLKDFW----ENADQQAYFDLYANTARTIKAIDPQLRVGGPStagAAWV-PELLAF-------------AAK 235
Cdd:cd21510   101 YYEVMNEPFVHAVDfyhdGGTTWEEIAEFHNEVAKAVKARNPDVKVGGYT---SAFPdFELNDFghwnermkffidtAGE 177
                          90
                  ....*....|...
gi 1275072804 236 NtlpIDFVTTHTY 248
Cdd:cd21510   178 N---MDFYSIHLY 187
 
Name Accession Description Interval E-value
XynB COG3664
Beta-xylosidase [Carbohydrate transport and metabolism];
16-517 0e+00

Beta-xylosidase [Carbohydrate transport and metabolism];


Pssm-ID: 442881  Cd Length: 490  Bit Score: 591.12  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  16 TSAMAQHAAPRTIQLDLATAGAPVDRFYDLSVGSDFPGTlirsdaqahlvpavhelgFRYLRFHDVFHDVLGTVK-TVDG 94
Cdd:COG3664    25 KVAGPMKPLWAWFGYDEPNYTYMKDGKKLLSEGAGLSPV------------------FRYIRFHGLFHDDMGVYReDADG 86
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  95 KLVYDWTKLDQLYDALLAKRIRPFVELGFTPSAMKTSEQTLFYWKGNTSHP-DPAKWTQLIDAYVRHIRARYGAEEVRQW 173
Cdd:COG3664    87 NPVYNFTYVDKIFDFLLELGMKPFVELGFMPEALASGPQTVFWWKGNVTPPkDYAKWADLVRAFVRHLIDRYGIDEVRSW 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 174 YFEVWNEPNLKDFWEnADQQAYFDLYANTARTIKAIDPQLRVGGPSTAG--AAWVPELLAFAAKNTLPIDFVTTHTYGVD 251
Cdd:COG3664   167 YFEVWNEPNLSGFWK-GTQEEYFKLYDYTARAVKSVDPRLRVGGPATAGgaAAWLPDFLEHCAKNGVPVDFVSTHAYGTD 245
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 252 GGFldengkqDTKLSASPDAIVGDVRRVRAQIQASPFPDLPLYFTEWSSSYTPRDFVHDSYISAPYILTKLKQVRGMVQG 331
Cdd:COG3664   246 PGF-------DGQLSMNPDAVLRDVEKVRKLIAASAFPNLPLHITEWNTSYTPRDPYHDTAFYAAYIAKSLKRAGDLADS 318
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 332 MSYWTYTDLFEEPGPPPTPFHGGFGLMNREGIRKPAWFAYKYLNALKGRDVPLSDTHALAAVDG-KRVAALAWDWQQPvq 410
Cdd:COG3664   319 MSYWTFSDIFEEAGPPTQPFHGGFGLLNTNGIKKPVYHAFRMLNRLGGERLAVGDDDAVATRDDdGRVAVLVWNYHDD-- 396
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 411 avsntpfytkqVPATDSAPLRVRMTHVPAGTYQLQVRKTGYRRNDPLSLYIDMGMPNDLAPRQLTQLQQATRDAPEqdRR 490
Cdd:COG3664   397 -----------DPAGPARTVELTLTGLPAGKYRLTVYRVDEEHGNAYAAWLEMGSPQQPTREQIAELKAAAELQTS--PE 463
                         490       500
                  ....*....|....*....|....*..
gi 1275072804 491 VRVGADGVVEINVPMRSNDVVLLTLEP 517
Cdd:COG3664   464 VVVVADGKLTLDLTLPRNSVVLIELTP 490
Glyco_hydro_39 pfam01229
Glycosyl hydrolases family 39;
28-506 9.63e-100

Glycosyl hydrolases family 39;


Pssm-ID: 426141  Cd Length: 472  Bit Score: 308.77  E-value: 9.63e-100
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804  28 IQLDLATAGAPVDRFYDLSVGSDFPGTLIRSDAQAHLVPAVHELGFRYLRFHDVFHDVLGTV-KTVDGKLVYDWTKLDQL 106
Cdd:pfam01229   3 IKVDAARDLRKLTPFWRSCVGFCPPLPALQADWDQQLNLAYPHIGFEYVRGHGWLLDDITAYrESVDQGLFYNFTHIDRI 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 107 YDALLAKRIRPFVELGFTPSAMKTSEQTLFYWKGNTSHP-DPAKWTQLIDAYVRHIRARYGAEEVRQWYFEVWNEPNLKD 185
Cdd:pfam01229  83 LDLLLENGLLPFFELGFMPKRLASGTPTVFFWEGNFTPPkQYEEWKNLVSLLARHYIGRYGLDEVSKWNFETWNEPNLKD 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 186 F-WENADQQAYFDLYANTARTIKAIDPQLRVGGPSTAGAAWVPELLAFAAKNTLPIDFVTTHTYGVDGGFLDENGKQDTK 264
Cdd:pfam01229 163 FdWVDMTEQEYFNLYKACAEAIKEVSPNLKVGGPADSFDPWIRSLLEFCYNGNVPLDFISLHAYSKKGAGSSILILEEEM 242
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 265 LSASPDAIVGDVRRVRAQiqaspFPDLPLYFTEWSSSYTPRDFVHDSYISAPYILTKLKQVRGMVQGMSYWTYTDLFEEP 344
Cdd:pfam01229 243 ASEYMLNEVKQVRELIPE-----FPDLPVYNTEANPSWSPPQPWHDDPTYAAYVVKVIAQHQDLPDANSYWTFRDVFEEN 317
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 345 GPPPTPFHGGFGLMNREGIRKPAWFAYKYLNALKGRDV--PLSDTH----ALAAVDGKRVAALAWDWQQPVQAVSNTPFY 418
Cdd:pfam01229 318 DNAFLSFHGGFGLNNTHPIPKPVLTAFKLLALLDGEQLwaEVSDSNhtvgVIASRHDPSGALIAWNEIVLIYSSDDTTAH 397
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 419 tkqvpATDSAPLRVRMTHVPAGTYQLQVRKTGYRRNDPLSLYIDMGmpndlAPRQLTQlqqatrdapEQDRRVRVGADGV 498
Cdd:pfam01229 398 -----PDKEYPVTLRLNGPVGFKLVYIKLMIDEDHGNPWGTWQHMG-----RPVFPSK---------EQIRRLRDAEKPK 458

                  ....*...
gi 1275072804 499 VEINVPMR 506
Cdd:pfam01229 459 AEAPRPFP 466
agarase_cat cd21510
alpha-beta barrel catalytic domain of agarase, such as GH86-like endo-acting agarases ...
174-248 2.26e-05

alpha-beta barrel catalytic domain of agarase, such as GH86-like endo-acting agarases identified in non-marine organisms; Typically, agarases (E.C. 3.2.1.81) are found in ocean-dwelling bacteria since agarose is a principle component of red algae cell wall polysaccharides. Agarose is a linear polymer of alternating D-galactose and 3,6-anhydro-L-galactopyranose. Endo-acting agarases, such as glycoside hydrolase 16 (GH16) and GH86 hydrolyze internal beta-1,4 linkages. GH86-like endo-acting agarase of this protein family has been identified in the human intestinal bacterium Bacteroides uniformis. This acquired metabolic pathway, as demonstrated by the prevalence of agar-specific genetic cluster called polysaccharide utilization loci (PULs), varies considerably between human populations, being much more prevalent in a Japanese sample than in North America, European, or Chinese samples. Agarase activity was also identified in the non-marine bacterium Cellvibrio sp.


Pssm-ID: 411072  Cd Length: 321  Bit Score: 46.41  E-value: 2.26e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 174 YFEVWNEPNLKDFW----ENADQQAYFDLYANTARTIKAIDPQLRVGGPStagAAWV-PELLAF-------------AAK 235
Cdd:cd21510   101 YYEVMNEPFVHAVDfyhdGGTTWEEIAEFHNEVAKAVKARNPDVKVGGYT---SAFPdFELNDFghwnermkffidtAGE 177
                          90
                  ....*....|...
gi 1275072804 236 NtlpIDFVTTHTY 248
Cdd:cd21510   178 N---MDFYSIHLY 187
AbfA COG3534
Alpha-L-arabinofuranosidase [Carbohydrate transport and metabolism];
144-258 5.17e-03

Alpha-L-arabinofuranosidase [Carbohydrate transport and metabolism];


Pssm-ID: 442755 [Multi-domain]  Cd Length: 487  Bit Score: 39.34  E-value: 5.17e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1275072804 144 HPDPAKWTQLidayvrhiRARYGAEE---VRqwYFEVWNEPnlkdfW---ENADQQAYFDLYANTARTIKAIDPQLR--V 215
Cdd:COG3534   142 HPGGTPLSDL--------RRANGREEpwkVK--YWGLGNEP-----WqcgGHMTAEEYARLAREYATAMRNVDPSIElvA 206
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*..
gi 1275072804 216 GGPSTAGAAWVPELLAFAAKNtlpIDFVTTHTY----GVDGGFLDEN 258
Cdd:COG3534   207 CGSSGDDYEWTETVLEHAYDL---VDGISLHYYygnkGSATGFDEGD 250
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH